Physical biomarkers for human hematopoietic stem and progenitor cells

Adhesion of hematopoietic stem and progenitor cells (HSPCs) to the bone marrow niche plays critical roles in the maintenance of the most primitive HSPCs. The interactions of HSPC−niche interactions are clinically relevant in acute myeloid leukemia (AML), because (i) leukemia-initiating cells adhered...

Full description

Saved in:
Bibliographic Details
Main Authors: Tanaka, Motomu (Author) , Thoma, Judith (Author) , Poisa-Beiro, Laura (Author) , Wuchter, Patrick (Author) , Eckstein, Volker (Author) , Dietrich, Sascha (Author) , Pabst, Caroline (Author) , Müller-Tidow, Carsten (Author) , Ohta, Takao (Author) , Ho, Anthony Dick (Author)
Format: Article (Journal)
Language:English
Published: 3 May 2023
In: Cells & development
Year: 2023, Volume: 174, Pages: 1-10
ISSN:2667-2901
DOI:10.1016/j.cdev.2023.203845
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.cdev.2023.203845
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S2667290123000219
Get full text
Author Notes:Motomu Tanaka, Judith Thoma, Laura Poisa-Beiro, Patrick Wuchter, Volker Eckstein, Sascha Dietrich, Caroline Pabst, Carsten Müller-Tidow, Takao Ohta, Anthony D. Ho
Description
Summary:Adhesion of hematopoietic stem and progenitor cells (HSPCs) to the bone marrow niche plays critical roles in the maintenance of the most primitive HSPCs. The interactions of HSPC−niche interactions are clinically relevant in acute myeloid leukemia (AML), because (i) leukemia-initiating cells adhered to the marrow niche are protected from the cytotoxic effect by chemotherapy and (ii) mobilization of HSPCs from healthy donors' bone marrow is crucial for the effective stem cell transplantation. However, although many clinical agents have been developed for the HSPC mobilization, the effects caused by the extrinsic molecular cues were traditionally evaluated based on phenomenological observations. This review highlights the recent interdisciplinary challenges of hematologists, biophysicists and cell biologists towards the design of defined in vitro niche models and the development of physical biomarkers for quantitative indexing of differential effects of clinical agents on human HSPCs.
Item Description:Online verfügbar 26. April 2023, Artikelversion 3. Mai 2023
Gesehen am 04.07.2023
Physical Description:Online Resource
ISSN:2667-2901
DOI:10.1016/j.cdev.2023.203845